The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable excitement within the industry. A shift away from Schedule I status, often regarded as outdated and hindering https://yxzbookmarks.com/story20737389/marijuana-rescheduling-a-growth-catalyst